2011

1. Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis

   Clinical and Experimental Rheumatology

2. CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: A cohort study

   Arthritis Research and Therapy, Vol. 13, Núm. 4

3. Lack of association between ADIPOQ rs266729 and ADIPOQ rs1501299 polymorphisms and cardiovascular disease in rheumatoid arthritis patients

   Tissue Antigens, Vol. 77, Núm. 1, pp. 74-78

4. Lack of association between LEP rs2167270 (19 G>A) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis

   Clinical and Experimental Rheumatology, Vol. 29, Núm. 2, pp. 293-298

5. Lack of association between RETN rs1862513 polymorphism and cardiovascular disease in patients with rheumatoid arthritis

   Clinical and Experimental Rheumatology, Vol. 29, Núm. 1, pp. 19-25

6. Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis

   Clinical and Experimental Rheumatology, Vol. 29, Núm. 4, pp. 681-688

7. Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients

   Tissue Antigens, Vol. 77, Núm. 4, pp. 291-297